Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Real-world outcomes of Mantle Cell Lymphoma in Colombia: A multicenter cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMaría Angelina PérezMTMaría TamayoGAGabriel Ayala

Discussion

Loading...

Member takes

Overview

Cohort study shows a 5-year survival rate of 66.2% in Mantle Cell Lymphoma patients in Colombia, highlighting treatment access issues.

Key Points

  • To characterize clinical presentation, treatment patterns, and survival outcomes in MCL patients in Bogotá, Colombia.
  • Conducted a retrospective cohort study of 80 MCL patients diagnosed between 2010 and 2024.
  • Collected data on baseline characteristics, treatment regimens, and survival outcomes.
  • Analyzed overall survival using Kaplan-Meier estimates and log-rank tests; performed Cox regression for survival variables.
  • The 5-year overall survival rate was 66.2%, exceeding prior regional data.
  • Advanced-stage disease was common, with 80.7% in stage IV, and high-risk classifications were frequent.
  • Only 27% of patients received Rituximab maintenance, indicating barriers to treatment access.

Cite This Study

Pérez et al. (2025) studied this question.

synapsesocial.com/papers/693624dd4fa91c937236d200https://doi.org/10.1182/blood-2025-7102
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Contemporary real-world outcomes of mantle cell lymphoma in Colombia: Results from an expanded multicenter cohort.2026
  2. 2Real-world treatment and outcomes of Mantle Cell Lymphoma in Latin America: A multinational cohort analysis2025
  3. 3Clinicopathologic Characteristics and Survival Outcome of Patients With Mantle Cell Lymphoma: A North Indian Tertiary Care Center Experience2025 · 1 citations
  4. 4Treatment patterns and survival outcomes in patients with Mantle Cell Lymphoma: Interim report of the Asia-Pacific multinational prospective registry study2025 · 1 citations
  5. 5Real-world treatment and safety outcomes of patients with Mantle Cell Lymphoma in the United States2025